How Supplied
Methotrexate Injection is a clear, yellow, sterile solution available with preservative (multiple-dose vials) and preservative-free (single-dose vials) as follows:
| Strength/Fill volume | NDC number | Pack style |
|---|---|---|
With Preservative | ||
50 mg/2 mL (25 mg/mL) | 61703-350-38 | Carton containing five (5) multiple-dose vials |
Preservative-free | ||
1 g/40 mL (25 mg/mL) | 61703-408-41 | Carton containing one (1) single-dose vial |
| Carton contents | NDC |
|---|---|
Methotrexate Injection, With Preservative, 5 multiple-dose vials | |
50 mg/2 mL (25 mg/mL) | 61703-350-38 |
Preservative-free Methotrexate Injection, 1 single-dose vial | |
1 g/40 mL (25 mg/mL) | 61703-408-41 |
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light.
After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days.
Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.1
How Supplied
Methotrexate Injection is a clear, yellow, sterile solution available with preservative (multiple-dose vials) and preservative-free (single-dose vials) as follows:
| Strength/Fill volume | NDC number | Pack style |
|---|---|---|
With Preservative | ||
50 mg/2 mL (25 mg/mL) | 61703-350-38 | Carton containing five (5) multiple-dose vials |
Preservative-free | ||
1 g/40 mL (25 mg/mL) | 61703-408-41 | Carton containing one (1) single-dose vial |
| Carton contents | NDC |
|---|---|
Methotrexate Injection, With Preservative, 5 multiple-dose vials | |
50 mg/2 mL (25 mg/mL) | 61703-350-38 |
Preservative-free Methotrexate Injection, 1 single-dose vial | |
1 g/40 mL (25 mg/mL) | 61703-408-41 |
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light.
After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days.
Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.1
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.